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ABSTRACT
   Copyright 2018 by Ralli M. This is an open-access article distributed under Creative Commons Attribution 4.0 International License (CC BY 4.0), which allows 
to copy, redistribute, remix, transform, and reproduce in any medium or format, even commercially, provided the original work is properly cited.
cc
Granulomatosis with polyangiitis (GPA) is an anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides of  medium 
and small arteries, characterized by necrotizing granulomatous inflammation of  the upper and lower respiratory tract with coexist-
ing glomerulonephritis. We report a case of  GPA in a patient presenting with a six-month history of  spontaneous epistaxis, nasal 
obstruction and frontal headache. Nasal endoscopy showed a large nasal septum perforation and an anterior translucid mass in 
the right nasal fossa. Findings were confirmed by computed tomography (CT) scan with contrast. The patient underwent func-
tional transnasal endoscopic removal of  the mass; histological examination showed tissue features suggestive of  GPA; dosage of  
c-ANCA e p-ANCA antibodies confirmed GPA diagnosis. Nasal septum perforation has long been recognized as a feature of  
GPA, in which granulomatous destruction of  nasal cartilage can result in perforation and saddle-nose deformity. Prompt diagno-
sis of  GPA is important to initiate therapy which may be life-saving and organ sparing.
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INTRODUCTION 
Granulomatosis with polyangiitis (GPA), previously known as Wegener granulomatosis, is an anti-neutrophil cytoplasmic 
antibodies (ANCA)-associated vasculitides of  medium and small 
arteries, characterized by necrotizing granulomatous inflammation 
of  the upper (ear, nose, throat) and lower (lung) respiratory tract 
with coexisting glomerulonephritis (renal systems). Untreated gen-
eralized GPA is a serious disease that may lead to an irreversible 
organ damage as renal or lung failure.1-3 The estimated incidence 
of  GPA in Europe is 5-10 cases per 1 million population.4
 The disease is equally distributed between males and fe-
males and affects people at any age, but the most common age 
of  presentation of  GPA is the sixth and seventh decade of  life. 
In 80-95% of  the patient, the presenting symptoms of  GPA are 
otorhinolaryngological manifestations.5
 We report a case of  GPA in a patient presenting with a 
six-month history of  spontaneous epistaxis, nasal obstruction and 
frontal headache and evidence at physical examination of  a poly-
poid mass in the nasal fossae and an asymptomatic perforation of  
the nasal septum.
CASE REPORT
A 38-year-old women presented to the Otolaryngology Depart-
ment of  our University reporting a six-month history of  sponta-
neous epistaxis, nasal obstruction and frontal headache. Otolaryn-
gologic physical examination through nasal endoscopy showed an 
anterior perforation of  the nasal septum and a polypoid translucid 
mass in the anterior right nasal cavity. The patient reported to ha-
bitually smoke 20 cigarettes/die for 20-years and denied previous 
nasal surgery, nasal trauma, chronic use of  nasal decongestants, 
and assumption of  cocaine.
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 The patient performed maxillofacial computed tomog-
raphy (CT) scan with contrast that confirmed the presence of  a 
soft density polypoid mass occupying the anterior portion of  right 
nasal fossa associated with cartilaginous nasal septum perforation 
(Figure 1). General laboratory exams were within normal range. 
Inflammatory marker assays for C-reactive protein and erythrocyte 
sedimentation rate were within normal limits. In the clinical suspi-
cion of  a malignant condition, the patient 
 
 
 
 Underwent a trans-nasal endoscopic excision  of  the 
mass under general anesthesia. Histological examination showed 
mixed inflammatory cells T-lymphocytes (CD3+, CD56-), histio-
cytes (CD68R+) and granulocytes associated to fibrin necrotic ma-
terial and vascular structures with elastic lamina fragmentation and 
lumen obliteration. Due to the histological suspicion of  a vascu-
litides,  Dosage of  c-ANCA e p-ANCA antibodies revealed the 
presence of  GPA (the complete immunological tests are reported 
in Table 1). The post-operative course was uneventful, and the 
patient was sent to the Immunologic Department of  our hospital. 
No signs of  recurrence of  the diseases were observed one year 
after surgery.  
DISCUSSION
Granulomatosis with polyangiitis (GPA), previously known as We-
gener granulomatosis, is an idiopathic vasculitis involving medium 
and small arteries.
 Among patients with GPA, 80%-95% of  patients of  de-
velop head and neck manifestations during their life5 and often 
otorhinolaryngological symptoms are the presenting and sole signs 
of  the disease.
 In case of  a GPA developing only in Head and Neck re-
gion, this condition is called “limited GPA”, differing from more ad-
vanced form, named “generalized GPA”, characterized by systemic 
vasculitis with renal and/or pulmonary involvement and systemic 
symptoms such as fever and  asthenia. “Limited GPA” phenotype is 
more likely to affect young female patients, with a recurrent behav-
ior and often non-compliant to medical therapy.6 Nasal involve-
ment has long been recognized as a feature of  “Limited GPA” and 
usually starts in the septum area supplied by Kiesselbach plexus 
and then spreads to the paranasal sinuses.7 
 In our case, patient’s symptoms are related to sinonasal 
region, without systemic involvement. Nasal endoscopy reveled a 
large nasal septum perforation and an anterior translucid mass in 
the right nasal fossa. Presence of  a translucid mass in the middle 
meatus is often related to an inflammatory disease like nasal pol-
yps, although concomitant presence of  a nasal septum perforation 
(NSP) is unusual.
 In case of  a NPS is essential the exclusion of   cocaine 
previous use, due to the possibility of  an induced destruction of  
nasal septum.8
 NPS has long been recognized as a common feature of  
autoimmune disorders. As in our case, granulomatous destruc-
tion of  nasal cartilage can result in nasal septum perforation and 
may develop in advantaged stages to a saddle-nose deformity.9,10 
A recent systematic review of  the existing literature from Gun-
tupalli et al found that GPA and relapsing polychondritis are the 
autoimmune disorders most frequently related  with nasal septum 
perforation and comprises nearly 80% of  the reported cases of  au-
toimmune-related nasal septum perforation cases in the literature 
(Figure 2).11
 Proper and early diagnosis of  GPA is essential for immi-
nent therapy implementation and allows avoiding irreversible or-
gan damage.5 Diagnosis of  GPA may be challenging given various 
clinical manifestations, and may be difficult to distinguish from ne-
oplastic, infectious and inflammatory etiologies.2,12 Differential di-
agnosis must be done with malignant conditions as Natural Killer 
T-cell lymphoma; infectious disease such as tuberculosis, aspergil-
losis and leishmaniasis and inflammatory conditions as sarcoidosis.
Table 1. Patient’s Blood Test
Patient value Normal range
White blood cell (×103/mm3) 8,46 4,40-11,3
Platelet (×103/mm3) 306 150-450
Haemoglobin (g/dL) 14 12,5-15,5
Prothrobin time (INR) 0,93 0,80-1,20
c-ANCA (U) 55,80 <20
p-ANCA (U) <3,20 <20
VES (mm/h) 4,0 <35
PRC  (mg/L) 3 0-5
ENA (U) <0,50 <20
Figure 1: Axial Computed Tomography (CT) Scan without Contrast Showing a Soft 
Density Polypoid Mass Occupying the Anterior Portion of Right Nasal Fossa, Associated 
with Cartilaginous Nasal Septum Perforation. The Tissue Arises from the Cartilagineal 
Portion of Nasal Septum and is in Contact with the Lateral Wall of the Nose. Minimal 
Signs of Body Erosion are Present.  Around Structure and Maxillary Sinus are Not 
Involved.
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 Currently in clinical practice diagnosis is usually based on 
presence of  distinctive ANCA and biopsy of  affected organ.13 In 
the clinical suspicion of  GPA,  ANCA testing  is essential for  GPA 
diagnosis. c-ANCA (cytoplasmic anti-neutrophil cytoplasmic anti-
body) are quite specific for GPA, while p-ANCA (peri-nuclear-an-
ti-neutrophil cytoplasmic antibody) may be associated with other 
autoimmune conditions like inflammatory bowel disease, rheuma-
toid arthritis, autoimmune liver disease.  During active phases of  
the disease, the sensitivity and specificity of  testing for c-ANCA 
are 91% and 99%, respectively.14 In the generalized GPA, ANCA 
are elevated in 90%-95% of  patients, whereas in the limited stage 
of  GPA in the ear-nose-throat region, positive levels of  c-ANCA 
may occur in only 46%-70% of  patients.15 Cytoplasmic localization 
of  ANCA (c-ANCA) is 90-95% sensitive in acute generalized GPA 
and 60% sensitive in early or localized disease.16
 
 Biopsy is usually performed when ANCA testing is 
non-diagnostic or uncertain. Moreover in “limited GPA”, the role 
of  the biopsy increases, because predictive value of  c-ANCA is 
lower.13 Histological finding of  GPA is characterized by specific 
abnormalities, such as vasculitis, granulomas, giant cells and necro-
sis. The sensitivity and specificity of  tissue biopsy varies depending 
on the site of  active disease. In patients with nasal involvement, 
nasal biopsy should be considered early in the evaluation, although 
an high rate of  false negative is reported, comparing with  biopsy 
at other affected sites, thus repeated nasal biopsies are often re-
quired. 
 Although nasal manifestations are quite specific for GPA 
in head and neck, the occurrence of  GPA in other head and neck 
sites is not unusual. Audiovestibular symptoms are often under-
estimated, and may occur in 8% to 65% of  patients with GPA.17 
Typically auditory symptoms are characterized by sensorineural 
hearing-loss,18 although conductive hearing loss may also occur  in 
cases of  GPA involving the middle ear or Eustachian tube dys-
function.17 Audiometric patterns of  GPA are typically flat and may 
coexist with age-related high-frequency loss. Moreover sudden 
sensorineural hearing loss may also be a presenting symptom of  
GPA and  hearing  loss is often  a marker of  a worsening of  disease 
that may address to a specific treatment.17 (Other Head and Neck 
subsites may be involved in GPA, a summary of  most common 
feature is reported in Table 2).
 
 Awareness of  this condition is essential for clinical otorhi-
nolaryngologist, considering the various clinical manifestations  of  
GPA and a prompt diagnosis is essential to initiate specific therapy 
and avoid renal or lung failure.19
Table 2. Manifestation  of GPA in Head and Neck (H&N)
H&N subsite Frequency Symptoms
Nose and sinuses Frequent (>85%)
Nasal obstruction and discharge. 
Reduction of smell, cacosmia, epiphora. 
Perforations of nasal septum with “saddle nose” deformity.
Ear Frequent(19%-61%)
Frequent: Otitis media secondary to Eustachian Tube dysfunction
Sensorineural hearing loss in 5%-31% of GPA patients.
Rare: Sudden sensorineural hearing loss, vertigo, chronic mastoiditis facial paralysis secondary 
to bone destruction.
External ear manifestations as erythematous or ulcerated lesions.
Salivary glands rare Parotid or submandibular glands may be swollen and sore.
Larynx rare Subglottic stenosis in childhood.Larynx ulcers.
Oral cavity rare <20
Figure 2: Percentage of Reported Cases of Each Autoimmune Disease Associated with a 
Nasal Septum Perforation. GPA = granulomatosis with polyangiitis; CIMDL = cocaine-induced 
midline destructive lesion; SLE = systemic lupus erythematosus; IgG4 = immunoglobulin G4. 
Re-edited from Guntupalli L. et al.11
CONCLUSION 
GPA is an anti-neutrophil cytoplasmic antibodies (ANCA)-asso-
ciated vasculitides of  medium and small arteries. GPA may pres-
ent with an isolated nasal involvement. Immunological disorders 
like GPA should be suspected in patients presenting nasal septum 
perforation without history of  other possible causes of  nasal per-
foration, such as previous cocaine use or nasal surgery. Serological 
exams and  histological features  are essential  to confirm GPA 
diagnosis, especially in a  case of  a “limited GPA”. Prompt diagno-
sis of  GPA is important to initiate specific therapy which may be 
life-saving and organ sparing.
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